Mineralys Therapeutics, Inc. - MLYS
Director
Direct Buys
0
$0
0
Shares
Direct Sells
0
$0
0
Shares
Indirect Buys
1
$17.50 M
1,296,296
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
03/13/2025
|
03/17/2025 |
Buy
|
1,296,296 @ $13.50
|
$17,499,996 | 4,280,051 (43.45%) | Indirect - See footnotes |
Janux Therapeutics, Inc. - JANX
Director
10% owner
Direct Buys
0
$0
0
Shares
Direct Sells
0
$0
0
Shares
Indirect Buys
4
$79.04 M
2,024,041
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
03/07/2025
|
03/07/2025 |
Buy
|
110,206 @ $31.02
|
$3,418,590 | 10,141,287 (1.10%) | Indirect - See footnotes |
|
03/06/2025
|
03/07/2025 |
Buy
|
372,093 @ $30.78
|
$11,453,023 | 10,031,081 (3.85%) | Indirect - See footnotes |
|
03/05/2025
|
03/07/2025 |
Buy
|
341,742 @ $30.64
|
$10,471,352 | 9,658,988 (3.67%) | Indirect - See footnotes |
|
10/18/2024
|
10/22/2024 |
Buy
|
1,200,000 @ $44.75
|
$53,700,000 | 9,317,246 (14.78%) | Indirect - See footnotes |
89Bio, Inc. - ETNB
Director
10% owner
Direct Buys
0
$0
0
Shares
Direct Sells
0
$0
0
Shares
Indirect Buys
1
$50.00 M
5,714,285
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
01/30/2025
|
02/03/2025 |
Buy
|
5,714,285 @ $8.75
|
$49,999,994 | 19,554,319 (41.29%) | Indirect - See Footnotes |
Tyra Biosciences, Inc. - TYRA
Director
10% owner
Direct Buys
0
$0
0
Shares
Direct Sells
0
$0
0
Shares
Indirect Buys
1
$19.84 M
1,220,681
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
11/08/2024
|
11/13/2024 |
Buy
|
1,220,681 @ $16.25
|
$19,836,066 | 8,697,956 (16.33%) | Indirect - See footnotes |
An2 Therapeutics, Inc. - ANTX
10% owner
Direct Buys
0
$0
0
Shares
Direct Sells
0
$0
0
Shares
Indirect Buys
0
$0
0
Shares
Indirect Sells
1
($3.81) M
-3,525,094
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
08/09/2024
|
08/13/2024 |
Sell
|
-3,525,094 @ $1.08
|
($3,807,102) | 300,853 (-92.14%) | Indirect - See footnotes |
Climb Bio, Inc. - CLYM
Director
10% owner
Direct Buys
0
$0
0
Shares
Direct Sells
0
$0
0
Shares
Indirect Buys
1
$49.95 M
13,008,546
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
06/27/2024
|
07/01/2024 |
Buy
|
13,008,546 @ $3.84
|
$49,952,817 | 2,866,375 (-128.26%) | Indirect - See footnotes |
Aerovate Therapeutics, Inc. - AVTE
Director
10% owner
Direct Buys
0
$0
0
Shares
Direct Sells
0
$0
0
Shares
Indirect Buys
1
$1.55 M
928,110
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
06/17/2024
|
06/20/2024 |
Buy
|
928,110 @ $1.67
|
$1,549,944 | 7,893,678 (13.32%) | Indirect - See footnotes |